Answers are grounded in this paper and cite their sources.
In 2018, the FDA cleared deep transcranial magnetic stimulation (dTMS) with the H7 coil for obsessive-compulsive disorder (OCD) treatment following a successful pilot randomized-controlled trial (RCT) [1] and a subsequent double-blinded placebo-controlled (DBPC) multicenter trial [2]. Two years later, TMS with the D-B80 coil was also FDA-cleared for the same indication on the basis of claimed substantial equivalence. While both coils appear to be bent figure- 8 coils, they differ in diameter of their circular wings and distance between the two wings.
No takes yet. Share an insight, caveat, or question.
Tzirini et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: